PL365071A1 - Orally administered controlled delivery system for once daily administration of ciprofloxacin - Google Patents

Orally administered controlled delivery system for once daily administration of ciprofloxacin

Info

Publication number: PL365071A1
Authority: PL; Poland
Prior art keywords: ciprofloxacin; delivery system; orally administered; once daily; daily administration
Prior art date: 2000-03-03

Application number

PL01365071A

Other languages

English (en)

Polish (pl)

Inventor

Naresh Talwar

John N. Staniforth

Ashok Rampal

Gour Mukherji

Badri N. Vishwanathan

Brij Khera

Original Assignee

Ranbaxy Laboratories Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-02-28

Publication date

2004-12-27

2001-02-28 Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited

2004-12-27 Publication of PL365071A1 publication Critical patent/PL365071A1/xx

Links

MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title 2
229960003405 ciprofloxacin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL01365071A 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin PL365071A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51788700A	2000-03-03	2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number	Publication Date
PL365071A1 true PL365071A1 (en)	2004-12-27

Family

ID=24061635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01365071A PL365071A1 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin

Country Status (31)

Country	Link
EP (1)	EP1263409A1 (es)
JP (1)	JP2003525229A (es)
KR (1)	KR20030009374A (es)
CN (1)	CN1420763A (es)
AP (2)	AP2001002084A0 (es)
AR (1)	AR032614A1 (es)
AU (1)	AU3589701A (es)
BG (1)	BG107055A (es)
BR (1)	BR0108958A (es)
CA (1)	CA2400950A1 (es)
CZ (1)	CZ20022883A3 (es)
DO (1)	DOP2001000130A (es)
EA (1)	EA200200914A1 (es)
EC (1)	ECSP013952A (es)
EE (1)	EE200200497A (es)
GT (1)	GT200100033A (es)
HN (1)	HN2001000038A (es)
HR (1)	HRP20020715A2 (es)
HU (1)	HUP0204417A3 (es)
IL (1)	IL151553A0 (es)
IS (1)	IS6532A (es)
MX (1)	MXPA02008568A (es)
NO (1)	NO20024108L (es)
NZ (1)	NZ520927A (es)
OA (1)	OA12381A (es)
PE (1)	PE20011113A1 (es)
PL (1)	PL365071A1 (es)
SK (1)	SK12542002A3 (es)
WO (1)	WO2001064183A1 (es)
YU (1)	YU66202A (es)
ZA (1)	ZA200206764B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
US20030229101A1 (en) *	2002-06-06	2003-12-11	Sherman Bernard Charles	Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de)	2003-11-04	2005-06-09	Bayer Healthcare Ag	Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) *	2005-07-19	2008-05-28	Ethypharm	Gastroretentive formulations and manufacturing process thereof.
DE602006012962D1 (de) *	2006-07-19	2010-04-29	Tabuk Pharmaceutical Mfg Co	Pharmazeutische Zubereitungen von Ciprofloxacin
US10363288B2 (en)	2015-01-14	2019-07-30	National Jewish Health	Insulin mimotopes and methods of using the same
US20190070299A1 (en) *	2016-02-23	2019-03-07	Matripharm International Inc.	Dual-rate release formulation with high drug loading
EP3432877B1 (en)	2016-03-24	2023-01-11	ImmunoMolecular Therapeutics, Inc.	D-alpha-methyldopa for treating autoimmune disease
US11052060B2 (en)	2018-02-12	2021-07-06	The Regents Of The University Of Colorado, A Body Corporate	Compounds and methods for treating autoimmunity
US11013707B2 (en)	2018-03-23	2021-05-25	The Regents Of The University Of Colorado, A Body Corporate	Administration of oral methyldopa
CN109806237A (zh) *	2019-03-13	2019-05-28	悦康药业集团上海制药有限公司	一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096714A (en) *	1988-06-28	1992-03-17	Hauser-Kuhrts, Inc.	Prolonged release drug tablet formulations
JPH0624959A (ja) *	1991-10-04	1994-02-01	Bayer Yakuhin Kk	胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) *	1994-02-28	1995-08-31	Bayer Ag	Expandierbare Arzneiformen
DE19839057A1 (de) *	1998-08-28	2000-03-02	Koch Berthold	Spülluft-Regler für eine Trockenvorrichtung für Druckluft
ATE245414T1 (de) *	1998-09-14	2003-08-15	Ranbaxy Lab Ltd	Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe

2001
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/hu unknown
- 2001-02-28 EE EEP200200497A patent/EE200200497A/xx unknown
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 AR ARP010100957A patent/AR032614A1/es not_active Application Discontinuation
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/cs unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/zh active Pending
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/ko not_active Ceased
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/sk unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/xx unknown
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/ja not_active Withdrawn
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/pt not_active IP Right Cessation
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/es unknown
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Ceased
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 YU YU66202A patent/YU66202A/sh unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/ru unknown
- 2001-02-28 PL PL01365071A patent/PL365071A1/xx not_active Application Discontinuation
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 NZ NZ520927A patent/NZ520927A/xx unknown
- 2001-02-28 HR HRP20020715 patent/HRP20020715A2/hr not_active Application Discontinuation
- 2001-03-01 GT GT200100033A patent/GT200100033A/es unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/es not_active Application Discontinuation
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/es unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/es unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/es unknown
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/is unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/no unknown
- 2002-09-02 BG BG107055A patent/BG107055A/bg unknown

Also Published As

Publication number	Publication date
AP2001002084A0 (en)	2001-03-31
IS6532A (is)	2002-08-28
ECSP013952A (es)	2002-04-23
SK12542002A3 (sk)	2003-05-02
NZ520927A (en)	2003-06-30
AP1485A (en)	2005-10-31
GT200100033A (es)	2001-10-25
HUP0204417A2 (en)	2003-05-28
NO20024108L (no)	2002-10-25
BG107055A (bg)	2003-06-30
ZA200206764B (en)	2003-03-04
EA200200914A1 (ru)	2003-02-27
HN2001000038A (es)	2005-03-23
AP2002002627A0 (en)	2002-09-30
WO2001064183A1 (en)	2001-09-07
HRP20020715A2 (en)	2004-12-31
MXPA02008568A (es)	2003-02-24
CA2400950A1 (en)	2001-09-07
HUP0204417A3 (en)	2005-03-29
IL151553A0 (en)	2003-04-10
CZ20022883A3 (cs)	2003-04-16
KR20030009374A (ko)	2003-01-29
AR032614A1 (es)	2003-11-19
NO20024108D0 (no)	2002-08-28
DOP2001000130A (es)	2004-03-31
EP1263409A1 (en)	2002-12-11
EE200200497A (et)	2004-02-16
PE20011113A1 (es)	2001-10-14
OA12381A (en)	2004-09-06
AU3589701A (en)	2001-09-12
BR0108958A (pt)	2003-09-30
CN1420763A (zh)	2003-05-28
YU66202A (sh)	2005-09-19
JP2003525229A (ja)	2003-08-26

Similar Documents

Publication	Publication Date	Title
EP1091732A4 (en)	2006-01-18	ORAL EFFERVESCENT MEDICATION DELIVERY SYSTEM
AU4334700A (en)	2000-10-23	Pharmaceutical dosage form for pulsatile delivery of methylphenidate
AU2002216701A1 (en)	2002-05-27	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
HUP0302319A3 (en)	2013-04-29	Pharmaceutical composition for oral administration of active ingredient
AU2002243387A1 (en)	2002-07-16	Pharmaceutical dosage form for oral administration of low molecular weight heparin
AU2001230892A1 (en)	2001-07-31	Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
HUP0401281A3 (en)	2008-04-28	Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals
PL356358A1 (en)	2003-04-07	Solid dosage form of someticone for oral administration
AU2513900A (en)	2000-08-07	Drug dosage unit for buccal administration of steroidal active agents
AU2879100A (en)	2000-08-29	Formulation and system for intra-oral delivery of pharmaceutical agents
NO20014035D0 (no)	2001-08-20	System for oral administrasjon av medikament
AU2002235155A1 (en)	2002-06-18	Crystallization inhibition of drugs in transdermal drug delivery systems
IL145559A0 (en)	2002-06-30	Tolperison-containing pharmaceutical preparation for oral administration
GB2355656B (en)	2004-04-07	Pharmaceutical compositions for oral and topical administration
ITRM20010226A0 (it)	2001-04-24	Dispositivo impiantabile di altezza ridotta per la somministrazione di preparati medicinali.
IL151553A0 (en)	2003-04-10	Orally administered controlled delivery system for once daily administration of ciprofloxacin
AU5811996A (en)	1996-11-29	Nanoparticles for oral administration of pharmaceutical agen ts of low solubility
EP1207852A4 (en)	2009-11-11	ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
AU6528400A (en)	2001-03-19	Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
AU2001230898A1 (en)	2001-07-24	Formulations and methods for administration of pharmacologically or biologicallyactive compounds
HUP0303597A3 (en)	2006-03-28	Diposable vaginal cannula for the simultaneous administration of drugs in different forms
HK1051811A (en)	2003-08-22	Orally administered controlled delivery system for once daily administration of ciprofloxacin
IL155855A0 (en)	2003-12-23	Pharmaceutical formulation of gepirone for oral administration
SG97918A1 (en)	2003-08-20	A novel drug delivery system: formulation for fat-soluble drugs
AU2001295884A1 (en)	2002-04-08	Dispenser for endermic administration of drug

Legal Events

Date	Code	Title	Description
2008-11-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)